Cowealth Medical China Co.,Ltd. (SHA:603122)

Market Cap	5.19B
Revenue (ttm)	777.03M
Net Income (ttm)	-11.37M
Shares Out	398.05M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	0.13 (1.10%)
Ex-Dividend Date	Jul 14, 2025

Volume	32,383,946
Average Volume	15,683,024
Open	9.49
Previous Close	8.90
Day's Range	9.31 - 9.79
52-Week Range	5.56 - 9.79
Beta	0.70
RSI	95.05
Earnings Date	Oct 30, 2025

About Cowealth Medical China

Cowealth Medical China Co.,Ltd. distributes medical products for hospitals in China. The company offers reagents and consumables; in-vitro diagnostic products; and oncology and ophthalmology medical devices. It also provides integrated decision-making and analysis platform for hospital administrations. The company was founded in 1997 and is based in Shanghai, China.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 203
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603122

Financial Performance

In 2024, Cowealth Medical China's revenue was 939.14 million, a decrease of -14.05% compared to the previous year's 1.09 billion. Earnings were 27.57 million, a decrease of -41.58%.